Alkermes Falls 20% After FDA Refusal To File Letter
April 02, 2018 at 08:38 AM EDT
Shares of Alkermes Plc (NASDAQ: ALKS) lost more than 20 percentearly Monday morning after the U.S. Food and Drug Administration ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.